Sep 29

QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1167 - Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer

05:25pm - 05:30pm ET

Presenter(s)

Rachel Glicksman, MD - University of Toronto, Toronto, ON